Literature DB >> 19194739

Brain metastases in colorectal cancers.

Wah-Siew Tan1, Kok-Sun Ho, Kong-Weng Eu.   

Abstract

BACKGROUND: Although colorectal cancer is the most common cancer in Singapore, brain metastases associated with colorectal primaries are quite rare, with reported incidences ranging from less than 1% to 4%. This is a review of the incidence, presentation, and prognosis of brain secondaries from colorectal primaries in our institution.
METHODS: From a prospectively collected database, 4378 patients underwent surgery for colorectal cancers between 1995 and 2003. Patients who developed brain metastases were identified and their records reviewed retrospectively.
RESULTS: Twenty-seven patients who developed brain metastases were identified, for an incidence of 0.62%. Seventy-one percent of the patients had a tumor in the rectum or sigmoid; 92.6% of patients had metachronous brain secondaries. The median interval between surgery for the primary tumor and the discovery of a brain secondary was 27.5 months. The lung was the most common site of concurrent metastatic disease, with the discovery of a brain secondary a median of 9.7 months after diagnosis of the lung lesion. All patients were symptomatic. The majority of the patients received nonsurgical treatment for the brain lesion. Median survival after diagnosis of brain secondaries was 2.4 months.
CONCLUSIONS: The poor survival of the patients in our series could be due to late diagnosis. It may be recommended that a brain scan be performed to screen for a brain secondary when lung and/or liver metastases are discovered, especially in a patient with a left-sided cancer. This may lead to earlier diagnosis, amenability to surgical treatment, and improved survival and quality of life.

Entities:  

Mesh:

Year:  2009        PMID: 19194739     DOI: 10.1007/s00268-009-9919-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Resection of brain metastases from colorectal carcinoma in 73 patients.

Authors:  M Wroński; E Arbit
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

2.  Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer.

Authors:  Thomas Anthony; Clifford Simmang; Neil Hyman; Donald Buie; Donald Kim; Peter Cataldo; Charles Orsay; James Church; Daniel Otchy; Jeffery Cohen; W Brian Perry; Gary Dunn; Janice Rafferty; C Neal Ellis; Jan Rakinic; Phillip Fleshner; Thomas Stahl; Sharon Gregorcyk; Charles Ternent; John W Kilkenny; Mark Whiteford
Journal:  Dis Colon Rectum       Date:  2004-05-04       Impact factor: 4.585

Review 3.  The role of positron emission tomography in the management of recurrent colorectal cancer: a review.

Authors:  A J M Watson; S Lolohea; G M Robertson; F A Frizelle
Journal:  Dis Colon Rectum       Date:  2007-01       Impact factor: 4.585

4.  Brain metastases from colorectal cancer.

Authors:  T D Alden; J W Gianino; T J Saclarides
Journal:  Dis Colon Rectum       Date:  1996-05       Impact factor: 4.585

5.  Risk and patterns of brain metastases in colorectal cancer: 27-year experience.

Authors:  F C Ko; J M Liu; W S Chen; J K Chiang; T C Lin; J K Lin
Journal:  Dis Colon Rectum       Date:  1999-11       Impact factor: 4.585

6.  Brain metastases from colorectal carcinoma. The long term survivors.

Authors:  G F Farnell; J C Buckner; T L Cascino; M J O'Connell; P J Schomberg; V Suman
Journal:  Cancer       Date:  1996-08-15       Impact factor: 6.860

7.  Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.

Authors:  Christopher E Desch; Al B Benson; Mark R Somerfield; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; David G Pfister; Katherine S Virgo; Nicholas J Petrelli
Journal:  J Clin Oncol       Date:  2005-10-31       Impact factor: 44.544

8.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Faith G Davis; Fawn D Vigneau; Ping Lai; Raymond E Sawaya
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

9.  A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.

Authors:  R M Auchter; J P Lamond; E Alexander; J M Buatti; R Chappell; W A Friedman; T J Kinsella; A B Levin; W R Noyes; C J Schultz; J S Loeffler; M P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-04-01       Impact factor: 7.038

Review 10.  Follow-up of patients with curatively resected colorectal cancer: a practice guideline.

Authors:  Alvaro Figueredo; R Bryan Rumble; Jean Maroun; Craig C Earle; Bernard Cummings; Robin McLeod; Lisa Zuraw; Caroline Zwaal
Journal:  BMC Cancer       Date:  2003-10-06       Impact factor: 4.430

View more
  14 in total

1.  Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience.

Authors:  Christos Fountzilas; Katherine Chang; Brian Hernandez; Joel Michalek; Richard Crownover; John Floyd; Devalingam Mahalingam
Journal:  J Gastrointest Oncol       Date:  2017-02

2.  Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center.

Authors:  Xiao-Bing Jiang; Qun-Ying Yang; Ke Sai; Xiang-Heng Zhang; Zhong-Ping Chen; Yong-Gao Mou
Journal:  Tumour Biol       Date:  2011-09-13

3.  Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution.

Authors:  K Damiens; J P M Ayoub; B Lemieux; F Aubin; W Saliba; M P Campeau; M Tehfe
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

4.  Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.

Authors:  Christine Heisterkamp; Tiina Haatanen; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2010-01-26       Impact factor: 3.621

Review 5.  Adult brain tumors in Sub-Saharan Africa: A scoping review.

Authors:  Ulrick Sidney Kanmounye; Claire Karekezi; Arsene Daniel Nyalundja; Ahmed K Awad; Tsegazeab Laeke; James A Balogun
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

6.  microRNA expression profiles in human colorectal cancers with brain metastases.

Authors:  Zhenyang Li; Xiaodong Gu; Yantian Fang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

7.  A survival score for patients with brain metastases from less radiosensitive tumors treated with whole-brain radiotherapy alone.

Authors:  L Dziggel; B Segedin; N H Podvrsnik; I Oblak; S E Schild; D Rades
Journal:  Strahlenther Onkol       Date:  2013-07-18       Impact factor: 3.621

8.  Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO).

Authors:  Pierina Navarria; Giuseppe Minniti; Elena Clerici; Tiziana Comito; Salvatore Cozzi; Valentina Pinzi; Laura Fariselli; Patrizia Ciammella; Silvia Scoccianti; Valentina Borzillo; Paola Anselmo; Ernesto Maranzano; Veronica Dell'acqua; Barbara Jereczek-Fossa; Niccolò Giaj Levra; Anna Maria Podlesko; Emilia Giudice; Michela Buglione di Monale E Bastia; Sara Pedretti; Alessio Bruni; Isa Bossi Zanetti; Simona Borghesi; Fabio Busato; Francesco Pasqualetti; Fabiola Paiar; Marta Scorsetti
Journal:  Br J Radiol       Date:  2020-10-22       Impact factor: 3.039

9.  Is there an Ethnic Predisposition to Developing Brain Metastases (BM) in Asian Patients with Colorectal Cancer?

Authors:  Kerri McGovern; Melissa H Smith; Antonia Maloney; Jyothi Jose; Muhammad Wasif Saif
Journal:  Cancer Med J       Date:  2020-05-19

Review 10.  Brain metastases in gastrointestinal cancers: is there a role for surgery?

Authors:  Johannes Lemke; Jan Scheele; Thomas Kapapa; Silvia von Karstedt; Christian Rainer Wirtz; Doris Henne-Bruns; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2014-09-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.